Literature DB >> 9260974

Blunted blood pressure response to central sympathoinhibition in normotensive blacks: increased importance of nonsympathetic factors in blood pressure maintenance in blacks.

C C Lang1, C M Stein, H B He, F J Belas, I A Blair, M Wood, A J Wood.   

Abstract

Enhanced sympathetic reactivity may predispose blacks to the development of hypertension and may occur because of increased sympathetic stimulation and/or attenuated sympathoinhibition. A potential site for such attenuated sympathetic inhibition may be at the level of central alpha2-adrenergic receptors, which play an important role in the feedback inhibition of norepinephrine release. We used cumulative doses (1, 2, and 3 microg/kg I.V.) of the centrally acting alpha2-adrenergic agonist clonidine to measure the sensitivity of alpha2-adrenoceptor-mediated sympathoinhibition and the resultant hypotensive response in 8 normotensive blacks and 10 normotensive whites. Sympathetic activity was determined by radioisotope dilution methodology. Basal norepinephrine spillover was similar in blacks (0.80+/-0.14 microg/min) and whites (0.73+/-0.19 microg/min, P=NS) and after clonidine decreased significantly in both blacks (0.21+/-0.07 microg/min, P<.0001) and whites (0.24+/-0.06 microg/min, P<.0001), with no difference between the groups (P=NS). Despite this similar degree of sympathoinhibition, the hypotensive response to clonidine was markedly blunted in blacks, such that mean arterial pressure decreased by only 10% in blacks but by 21% in whites (P<.0001). The smaller blood pressure decrement after clonidine in normotensive blacks, in the face of an equal degree of sympathoinhibition, suggests that even when sympathetic tone is decreased to the same level in blacks and whites, normotensive blacks have less reduction in blood pressure than whites, implying that nonadrenergic mechanisms contribute more to blood pressure maintenance in blacks than whites. Whether a similar interethnic difference in response to sympathoinhibition occurs in hypertensive patients is as yet unknown.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9260974     DOI: 10.1161/01.hyp.30.2.157

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  7 in total

Review 1.  Heart failure in African Americans: unique etiology and pharmacologic treatment responses.

Authors:  Clyde W Yancy
Journal:  J Natl Med Assoc       Date:  2003-01       Impact factor: 1.798

Review 2.  The role of race in heart failure therapy.

Authors:  Clyde W Yancy
Journal:  Curr Cardiol Rep       Date:  2002-05       Impact factor: 2.931

3.  A longitudinal study in youth of heart rate variability at rest and in response to stress.

Authors:  Zhibin Li; Harold Snieder; Shaoyong Su; Xiuhua Ding; Julian F Thayer; Frank A Treiber; Xiaoling Wang
Journal:  Int J Psychophysiol       Date:  2009-03-10       Impact factor: 2.997

4.  Function and structure of resistance vessels in black and white people.

Authors:  Zhila Taherzadeh; Lizzy M Brewster; Gert A van Montfrans; Ed VanBavel
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-06       Impact factor: 3.738

Review 5.  Heart failure management in African Americans: meeting the challenge.

Authors:  Jean-Bernard Durand
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-04       Impact factor: 3.738

6.  Hypertension in Obese Black Women is Not Caused by Increased Sympathetic Vascular Tone.

Authors:  Alejandro Marinos; Alfredo Gamboa; Jorge E Celedonio; Brock A Preheim; Luis E Okamoto; Claudia E Ramirez; Amy C Arnold; Andre Diedrich; Italo Biaggioni; Cyndya A Shibao
Journal:  J Am Heart Assoc       Date:  2017-11-18       Impact factor: 5.501

7.  The efficacy and tolerability of nebivolol in hypertensive African American patients.

Authors:  Elijah Saunders; William B Smith; Karen B DeSalvo; Will A Sullivan
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-11       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.